• Dr. Mark H. Deierhoi joined the UAB Department of Surgery in 1986. He has been instrumental in the evolution of transplantation surgery at UAB. He currently serves in the renal transplant program. He also sees patients at the VA Hospital.

    Dr. Deierhoi has served widely in his field, most notable with the Southeastern Organ Procurement Foundation assuming numerous committee and leadership roles with the foundation including presiding in 2003.

    A consistently funded researcher, Dr. Deierhoi has published over 85 journal manuscripts as well as book chapters. He has made presentations to conferences regionally, nationally and internationally.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Abnormal time-zero histology is predictive of kidney transplant outcomesClinical Transplantation.  36. 2022
    2020 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center ExperienceAnnals of Surgery.  271:177-183. 2020
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney ChainAnnals of Surgery.  270:639-646. 2019
    2018 Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the USJournal of the American College of Surgeons.  226:615-621. 2018
    2015 Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysisAmerican Journal of Kidney Diseases.  66:84-90. 2015
    2013 Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patientsAmerican Journal of Kidney Diseases.  62:1122-1129. 2013
    2013 Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomesClinical Journal of the American Society of Nephrology.  8:1750-1755. 2013
    2011 Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturationAmerican Journal of Kidney Diseases.  58:437-443. 2011
    2009 Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center: Brief communicationAmerican Journal of Transplantation.  9:1671-1673. 2009
    2008 Systolic dysfunction portends increased mortality among those waiting for renal transplantJournal of the American Society of Nephrology.  19:1190-1196. 2008
    2007 Predictors of Survival in Patients With End-Stage Renal Disease Evaluated for Kidney TransplantationAmerican Journal of Cardiology.  100:1020-1025. 2007
    2007 Racial Disparities in Renal Allograft Survival: A Public Health Issue?Journal of the American College of Surgeons.  204:894-902. 2007
    2005 Multi-organ transplantation: Is there a protective effect against acute and chronic rejection?Journal of Heart and Lung Transplantation.  24:1828-1833. 2005
    2004 Increased Kidney Transplantation Utilizing Expanded Criteria Deceased Organ Donors with Results Comparable to Standard Criteria Donor TransplantAnnals of Surgery.  239:688-697. 2004
    2004 "High-risk" renal transplantation: evolving definitions at a single center.Clinical transplants.  121-126. 2004
    2004 Donor nephrectomy: A comparison of techniques and results of open, hand assisted and full laparoscopic nephrectomyInvestigative urology.  171:40-43. 2004
    2003 Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantationAmerican Journal of Cardiology.  92:146-151. 2003
    2003 Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient managementClinical Transplantation.  17:77-88. 2003
    2003 The report of a national conference on the wait list for kidney transplantationAmerican Journal of Transplantation.  3:775-785. 2003
    2002 Hemodialysis arteriovenous fistula maturity: US evaluationRadiology.  225:59-64. 2002
    2002 The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patientsHuman Immunology.  63:364-374. 2002
    2001 Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-upTransplantation.  71:1681-1683. 2001
    2001 Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patientsKidney International.  60:2013-2020. 2001
    2001 Risk and benefit of coronary revascularization in renal transplant candidatesSeminars in Nephrology.  21:47-51. 2001
    2000 Improved outcomes in cadaveric renal allografts with pulsatile preservationClinical Transplantation.  14:543-549. 2000
    2000 Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantationClinical Transplantation.  14:533-542. 2000
    2000 Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapyClinical Transplantation.  14:439-448. 2000
    2000 Posttransplant lymphoproliferative disorder localized near the allograft in renal transplantationTransplantation.  69:809-814. 2000
    2000 Natural history of arteriovenous grafts in hemodialysis patientsAmerican Journal of Kidney Diseases.  36:68-74. 2000
    2000 US vascular mapping before hemodialysis access placementRadiology.  217:83-88. 2000
    1999 Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: Results of the U.S. multicenter FK506 kidney transplant study groupTransplantation.  68:1203-1205. 1999
    1999 Mycophenolate mofetil in cadaveric renal transplantationAmerican Journal of Kidney Diseases.  34:296-303. 1999
    1999 Predictors of adequacy of arteriovenous fistulas in hemodialysis patientsKidney International.  56:275-280. 1999
    1998 Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation (multiple letters)Transplantation.  65:142-145. 1998
    1998 Mycophenolate mofetil for the treatment of a first acute renal allograft rejectionTransplantation.  65:235-241. 1998
    1998 A multidisciplinary approach to hemodialysis access: Prospective evaluationKidney International.  53:473-479. 1998
    1998 Primate renal transplants using immunotoxinSurgery.  124:438-447. 1998
    1998 Renal retransplantation at the University of Alabama at Birmingham: incidence and outcome.Clinical transplants.  169-175. 1998
    1997 A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantationTransplantation.  63:977-983. 1997
    1996 A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejectionTransplantation.  62:594-599. 1996
    1996 Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejectionTransplantation.  61:722-729. 1996
    1996 Impact of donor/recipient size matching on outcomes in renal transplantationTransplantation.  61:383-388. 1996
    1996 Benefits of continued cyclosporine through an indigent drug programAmerican Journal of Kidney Diseases.  28:572-577. 1996
    1996 Correcting prolonged bleeding during renal transplantation with estrogen or plasmaJAMA Surgery.  131:160-165. 1996
    1995 Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipientsTransplantation.  60:225-232. 1995
    1995 Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomyTransplantation.  60:138-144. 1995
    1995 HLA matching in renal transplantationNew England Journal of Medicine.  332:752-753. 1995
    1995 A rapid flow cytometry assay for hla antibody detection using a pooled cell panel covering 14 serological crossreacting groupsTransplantation.  59:626-630. 1995
    1995 Progress in Renal Transplantation a Single Center Study of 3359 Patients over 25 YearsAnnals of Surgery.  221:446-458. 1995
    1994 Treatment of recurrent heart rejection with mycophenolate mofetil (RS- 61443): Initial clinical experienceJournal of Heart and Lung Transplantation.  13:444-450. 1994
    1994 Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-matchTransplantation.  57:47-54. 1994
    1994 The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443)Transplantation.  57:640-643. 1994
    1993 Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single centerAnnals of Surgery.  217:476-484. 1993
    1993 Tapering or Discontinuing Cyclosporine for Financial Reasons—A Single-Center ExperienceAmerican Journal of Kidney Diseases.  21:9-15. 1993
    1992 RS-61443 (mycophenolate mofetil): A multicenter study for refractory kidney transplant rejectionAnnals of Surgery.  216:513-519. 1992
    1992 Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys: A review of 855 operationsAnnals of Surgery.  215:606-617. 1992
    1992 Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppressionTransplantation.  53:103-109. 1992
    1992 RS-61443: successful rescue therapy in refractory renal rejection.Transplant International.  5 Suppl 1. 1992
    1992 Rs-61443—a phase i clinical trial and pilot rescue studyTransplantation.  53:428-432. 1992
    1992 The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting listTransplantation.  53:363-368. 1992
    1992 The impact of the UNOS mandatory sharing policy on recipients of the black and white races-experience at a single renal transplant centerTransplantation.  53:770-774. 1992
    1991 Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham.Clinical transplants.  179-191. 1991
    1991 Comparison of simple hypothermic storage, pulsatile perfusion with Belzer's gluconate-albumin solution, and pulsatile perfusion with UW solution for renal allograft preservationTransplantation Proceedings.  23:2394-2395. 1991
    1991 Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipientsTransplantation.  51:70-75. 1991
    1991 OKT3 first-dose reaction: Association with T cell subsets and cytokine releaseKidney International.  39:141-148. 1991
    1990 Age: A major determinant of renal dysfunctionTransplantation Proceedings.  22:365-367. 1990
    1990 Cyclosporine-induced changes in glomerular filtration rate and urea excretionAmerican Journal of Medicine.  88:497-502. 1990
    1990 Cyclosporine-induced changes in glomerular filtration rate and urea excretionAmerican Journal of Medicine.  88:497-502. 1990
    1990 Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.Clinical transplants.  289-300. 1990
    1990 Pulsatile perfusion preservation: Early posttransplant dialysis requirement predicts rapid graft lossTransplantation Proceedings.  22:446-447. 1990
    1989 A parametric analysis of the hazard of cancer after transplantationTransplantation Proceedings.  21:3201-3204. 1989
    1989 Anesthesia and pancreatic transplantationAnesthesiology Clinics.  7:515-549. 1989
    1989 Early graft function in primary and regraft recipients of paired cadaveric kidneysTransplantation Proceedings.  21:1274-1275. 1989
    1989 Lymphocytic IgM antibody in highly sensitized (>50% PRA) autologous negative renal allograft candidatesTransplantation Proceedings.  21:739-741. 1989
    1989 Successful renal allografts in recipients with a positive standard, DTE negative cross-matchTransplantation Proceedings.  21:746-747. 1989
    1989 Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera: Race, transplant history, and HLA-DR1 phenotypeTransplantation.  47:240-245. 1989
    1989 Sustained high panel reactive antibody levels in highly sensitized patients: Significance of continued transfusionsTransplantation Proceedings.  21:771-772. 1989
    1989 Use of cryopreserved donor bone marrow in cadaver kidney allograft recipientsTransplantation.  47:66-71. 1989
    1989 Use of cryopreserved donor bone marrow in cadaver kidney allograft recipientsTransplantation Proceedings.  21:1787-1789. 1989
    1988 A Comparison of OKT3 Monoclonal Antibody and Corticosteroids in the Treatment of Acute Renal Allograft RejectionAmerican Journal of Kidney Diseases.  11:86-89. 1988
    1988 Cyclosporine impairs the renal response to volume depletionTransplantation Proceedings.  20:568-571. 1988
    1988 Cyclosporine neurotoxicity in liver transplant recipients: Report of three casesTransplantation Proceedings.  20:116-118. 1988
    1988 Early graft loss in cyclosporine A-treated cadaveric renal allograft recipients receiving retransplants against previous mismatched HLA-A, -B, -DR donor antigensTransplantation Proceedings.  20:170-172. 1988
    1988 Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patientsAnnals of Surgery.  207:538-548. 1988
    1988 Preservation by pulsatile perfusion improves early renal allograft functionTransplantation Proceedings.  20:865-868. 1988
    1987 Quadruple immunosuppressive therapy in whole pancreas transplantation.Transplantation Proceedings.  19:2297-2299. 1987
    1987 Quadruple therapy for cadaver renal transplantation.Transplantation Proceedings.  19:1917-1919. 1987
    1987 A technique for transplantation of a large adult kidney into an infantTransplantation Proceedings.  19:2953-2955. 1987
    1987 Donor-specific transfusions in renal transplantation in children effect of azathioprine plus transfusionsTransplantation.  44:159-161. 1987
    1987 Influence of race on renal allograft survival in the pre- and postcyclosporine era.Clinical transplants.  217-233. 1987
    1986 Liver transplantation at the University of Wisconsin-Madison. 1986
    1986 Cadaver donor renal transplantation in insulin-dependent diabetics using cyclosporine and antilymphoblast globulinTransplantation Proceedings.  18:1720-1723. 1986
    1986 Lethal Graft-Vkrsus-Host disease in a recipient of a pancreas-spleen transplantTransplantation.  41:544-546. 1986
    1986 Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantationTransplantation Proceedings.  18:16-18. 1986
    1986 Two haplotype mismatched live donor renal transplantation in diabeticsTransplantation Proceedings.  18:1730-1732. 1986
    1985 Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantationTransplantation Proceedings.  17:2480-2481. 1985
    1985 The effect of pretransplant platelet transfusions on renal allograft survival and sensitization in dogsHLA.  25:28-32. 1985
    1985 Use of cell line K562 and autologous B lymphoblastoid cell lines to identify and remove autoantibodies from the serum of renal patientsTransplantation Proceedings.  17:171-173. 1985
    1984 Reactivity of lymphocyte cytotoxic autoantibodies from renal patients with cell line K562Transplantation.  38:557-558. 1984
    1983 Successful renal transplantation despite warm B cell antibodiesTransplantation.  36:207-209. 1983
    1981 Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipientsTransplantation Proceedings.  13:942-944. 1981

    Research Overview

  • renal transplantation
  • Education And Training

  • Northwestern Memorial Hospital, Internship
  • Northwestern Memorial Hospital, Residency
  • John Radcliffe Hospital - Oxford Univ., Postdoctoral Fellowship
  • University of Wisconsin Hospital & Clinics, Postdoctoral Fellowship
  • Full Name

  • Mark Deierhoi